Senior Medical Director, Hematology – Lymphoma; Lacutamab

Senior Medical Director, Hematology – Lymphoma (Lacutamab)

• Full-time
• Sobi
  
  Location:
  
  United States

At Sobi, we believe diversity drives innovation and inclusion creates stronger teams. We are committed to building a workplace where everyone feels valued and empowered to contribute. If this role excites you but you’re unsure if you meet every requirement, we encourage you to apply. Your unique perspective and experiences could be exactly what we need. We look forward to hearing from you!

At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.

Our mission and culture at Sobi North America get us excited to come to work every day, but here are a few more reasons to join our team:

• Competitive compensation for your work
• Generous time off policy
• Opportunity to broaden your horizons by attending popular conferences
• Emphasis on work/life balance
• Collaborative and team-oriented environment
• Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments

The Senior Medical Director, Hematology – Lymphoma leads the medical strategy for the Cutaneous T-Cell Lymphoma (CTCL) disease area within Hematology Medical Affairs, driving both brand medical strategy and external engagement with Opinion Leaders, community physicians, medical societies, and top accounts.

This role offers an experienced Medical Director the opportunity to lead medical strategy for a complex hematologic malignancy, engaging across the hematology-oncology, dermatology, and dermato-oncology communities while shaping how Sobi supports the CTCL patient and provider community. The Senior Medical Director will also lead launch preparatory efforts for lacutamab
, a humanized monoclonal antibody immunotherapy targeting KIR3DL2.

The Senior Medical Director serves as the lead medical voice for lymphoma and lacutamab, conceptualizing and implementing the US medical strategy for the disease area. This person reports to the
Vice President, Head of Hematology Medical Affairs
, partners closely with Field Medical to engage HCPs, medical organizations, payers, and patient advocacy groups, and acts as the medical lead on the Brand Team.

• Serve as the lead medical strategist for CTCL and lacutamab, providing strategic leadership for medical strategy, brand-aligned tactics, and external clinician engagement across academic, community, and multidisciplinary care settings
• Own launch readiness for lacutamab, including disease education, unmet need articulation, and evidence generation planning
• Contribute analytic expertise and insights to Medical Affairs deliverables

• Partner with Field Medical to develop and enhance KOL and key institution engagement plans, positioning Sobi as the scientific partner of choice for CTCL across the hematology-oncology community
• Collaborate with Field Medical on resource needs and development of field materials and tactics specific to CTCL and lacutamab
• Lead planning and execution of advisory boards and educational activities (webinars, medical round tables, symposia, congress presence)

• Generate and share medical insights with the field team; analyze insights to inform strategy and tactical adjustments
• Contribute to evidence generation projects, real-world evidence studies, and publications supporting the CTCL disease area and lacutamab

• Build strong collaborative relationships with Market Access,…